There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
2 April 2024
PB_2022_081
S6M-03233: Colette Stevenson: Access to Cannabis-based Products for Medicinal Use - That the Parliament welcomes the Home Office’s rescheduling of certain cannabis-based products for medicinal use (CBPMs) in 2018; notes the reported improvement in some children with treatment resistant epilepsy who take CBPMs, such as Cole Thomson, from East Kilbride, who it understands receives Bedrolite on private prescription; acknowledges the reported financial pressure that these prescriptions can place on families; further acknowledges the reported hesitancy of NHS consultants to prescribe unlicensed CBPMs due to the lack of robust evidence; notes the view that the rescheduling does not go far enough in assisting some patients, and the calls for a change in rules to allow GPs, who consider it appropriate, to prescribe unlicensed CBPMs where a non-NHS consultant has initiated that course of treatment; understands that the British Paediatric Neurology Association published its updated Guidance on the use of cannabis-based products for medicinal use in children and young people with epilepsy in October 2021, which, it considers, outlines concerns around the lack of randomised control trials demonstrating a product’s safety, quality and efficacy; acknowledges the Scottish Government’s reported commitment to collaborate with NHS England and the National Institute for Health Research to support research trials into medicinal cannabis in order to give NHS consultants the assurances that they need to consider prescribing CBPMs on the NHS; understands that, once a medicinal product has undergone clinical trials, it could be considered by the Medicines and Healthcare products Regulatory Agency for licensing and that this could lead to further consideration by organisations such as the National Institute for Health and Care Excellence, the Scottish Medicines Consortium and NHS Scotland; notes the calls for industry to run observational and clinical trials; believes that an increased evidence base offers the best opportunities for expansion of the range of CBPMs available from the NHS; welcomes the reported plans by Target Healthcare, which operates in East Kilbride, to produce CBPMs in Scotland, and notes the calls on the Scottish and UK governments to work together to find solutions on these issues.
Last updated:
2 April 2024
PB_2022_078
S6M-03233: Colette Stevenson: Access to Cannabis-based Products for Medicinal Use - That the Parliament welcomes the Home Office’s rescheduling of certain cannabis-based products for medicinal use (CBPMs) in 2018; notes the reported improvement in some children with treatment resistant epilepsy who take CBPMs, such as Cole Thomson, from East Kilbride, who it understands receives Bedrolite on private prescription; acknowledges the reported financial pressure that these prescriptions can place on families; further acknowledges the reported hesitancy of NHS consultants to prescribe unlicensed CBPMs due to the lack of robust evidence; notes the view that the rescheduling does not go far enough in assisting some patients, and the calls for a change in rules to allow GPs, who consider it appropriate, to prescribe unlicensed CBPMs where a non-NHS consultant has initiated that course of treatment; understands that the British Paediatric Neurology Association published its updated Guidance on the use of cannabis-based products for medicinal use in children and young people with epilepsy in October 2021, which, it considers, outlines concerns around the lack of randomised control trials demonstrating a product’s safety, quality and efficacy; acknowledges the Scottish Government’s reported commitment to collaborate with NHS England and the National Institute for Health Research to support research trials into medicinal cannabis in order to give NHS consultants the assurances that they need to consider prescribing CBPMs on the NHS; understands that, once a medicinal product has undergone clinical trials, it could be considered by PB/S6/22/78 the Medicines and Healthcare products Regulatory Agency for licensing and that this could lead to further consideration by organisations such as the National Institute for Health and Care Excellence, the Scottish Medicines Consortium and NHS Scotland; notes the calls for industry to run observational and clinical trials; believes that an increased evidence base offers the best opportunities for expansion of the range of CBPMs available from the NHS; welcomes the reported plans by Target Healthcare, which operates in East Kilbride, to produce CBPMs in Scotland, and notes the calls on the Scottish and UK governments to work together to find solutions on these issues.
Questions and Answers
Date answered:
17 March 2025
S6W-35936
I can advise Parliament, that today, I’m launching the roll out of a new National Planning Skills Commitment Plan.
Questions and Answers
Date answered:
13 July 2022
S6W-09370
The underspend against HM Treasury Scottish budgets for each financial year since 1999 is provided in the following table: Financial year Net fiscal underspend (£m) 2021-22* 650 2020-21 426 2019-20 256 2018-19 339 2017-18 453 2016-17 199 2015-16 137 2014-15 204 2013-14 176 2012-13 179 2011-12 179 2010-11 12 2009-10 119 2008-...
Last updated:
14 February 2023
BB20220304
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
3 March 2022
BB20220304
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Official Report
Meeting date:
13 November 2024
Rural Affairs and Islands Committee 13 November 2024
What is important is the control of medicines and any chemicals that are put into the environment.
Last updated:
12 March 2026
Budget Scrutiny SFRS Follow up Information
Operational Mitigation Measures SFRS has implemented a range of frontline control measures, including: • Additional PPE, supported by 36 reserve hubs, to ensure timely laundry and replacement (£1.4 m). • Airing racks and cages to reduce contaminant release from PPE (£267k). • External PPE storage boxes at 353 stations (£206k). • Shampoo/bodywash dispensers ...
Last updated:
5 March 2026
MinisterPBToConvener_18Feb26
Minister for Parliamentary Business and Veterans Graeme Dey MSP T: 0300 244 4000 E: [email protected] Kenneth Gibson MSP Convener Finance and Public Administration Committee Scottish Parliament EDINBURGH EH99 1SP ___ February 2026 18 February 2026 D ear Kenneth, I am writing under the terms of the Written Agreement between the Scottish Government and th e Finance and Public Administration Committee of the Scottish Parliament which requires thI ea mSc wotrtitisinhg M...
Last updated:
24 February 2026
Letter from the Convener of CEEAC Committee dated 13 June 2024
M artin Whitfield MSP The Scottish Parliament Convener EDINBURGH Standards, Procedures and Public EH99 1SP Appointments Committee By email [email protected] 13 June 2024 Dear Martin, Review of EU-related rules in Standing Orders The Standing Orders of the Scottish Parliament contain a range of rules which derive from membership of the Europea...
